US FDA issues guidance on modernizing statistical methods for clinical trials: Maryland Wednesday, January 14, 2026, 09:00 Hrs [IST] The US Food and Drug Administration today publ ...
The advent and proliferation of targeted modalities represent an evolutionary leap forward in drug development. By binding ...
January 13, 2026 - PRESSADVANTAGE - In the highly regulated field of medical device labeling translation, ensuring that ...
FDA agreed that data from the Phase 2a diSArm study support advancement of AP-SA02 to a Phase 3study First bacteriophage company to advance a clinical candidate to ...
Armata Pharmaceuticals, Inc. ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the ...
Laughing Water Capital reported a 3.9% annual return, emphasizing fundamental growth in core holdings despite a market ...
Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...
An independently managed investment subsidiary of Investindustrial Growth III SCSp (“Investindustrial”) has acquired Proveris Scientific Corporation (“Proveris”), a leader in the design and ...
When Jorie Kraus was diagnosed with an incurable rare disease, two young researchers created an AI tool to find a treatment.
MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare ConferenceInterim assessment and enrollment ...
ZHENJIANG, JIANGSU, CHINA, January 9, 2026 /EINPresswire.com/ -- In the vast and competitive global eyewear market, the ...